|
|
|
books
| book details |
Implementing a National Cancer Clinical Trials System for the 21st Century: Second Workshop Summary
By (author) Board on Health Care Services, By (author) National Cancer Policy Forum, Edited by Margie Patlak, Edited by Sharyl J. Nass, By (author) Institute of Medicine, By (author) An American Society of Clinical Oncology and Institute of Medicine Workshop
|
| on special |
normal price: R 1,379.95
Price: R 1,310.95
|
| book description |
The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program, the NCTN is comprised of more than 2,100 institutions and 14,000 investigators, who enroll more than 20,000 cancer patients in clinical trials each year across the United States and internationally. Recognizing the recent transformative advances in cancer research that necessitate modernization in how cancer clinical trials are run, as well as inefficiencies and other challenges impeding the national cancer clinical trials program, the NCI asked the IOM to develop a set of recommendations to improve the federally funded cancer clinical trials system. These recommendations were published in the 2010 report, A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. In early 2011, the NCPF and the American Society of Clinical Oncology (ASCO) held a workshop in which stakeholders discussed the changes they planned to implement in response to the IOM goals and recommendations. Two years later, on February 11-12, 2013, in Washington, DC, the NCPF and ASCO reconvened stakeholders to report on the changes they have made thus far to address the IOM recommendations. At this workshop, representatives from the NCI, the NCTN, comprehensive cancer centers, patient advocacy groups, the Food and Drug Administration (FDA), industry, and other stakeholders highlighted the progress that has been made in achieving the goals for a reinvigorated national cancer clinical trials system. Implementing a National Cancer Clinical Trials System for the 21st Century is a summary of that workshop. Table of Contents Front Matter Implementing a National Cancer Clinical Trials System for the 21st Century References Acronyms Appendix A: Workshop Statement of Task and Agenda Appendix B: Executive Summary of *A National Cancer Clinical Trials System for the 21st Century*
| product details |
Normally shipped |
Publisher | National Academies Press
Published date | 27 Oct 2013
Language |
Format | Paperback / softback
Pages | 110
Dimensions | 229 x 152 x 0mm (L x W x H)
Weight | 0g
ISBN | 978-0-3092-8724-1
Readership Age |
BISAC | medical / research
| other options |
Normally shipped |
Readership Age |
Normal Price | R 1,594.95
Price | R 1,514.95
| on special |
|
|
|
To view the items in your trolley please sign in.
| sign in |
|
|
|
| specials |
|
The Thing at 52 is a beautiful picture book about friendship, loneliness and learning how to say goodbye.
|
The Instant Sunday Times Bestseller Learn how to recognise and resist the daily attempts to control and manipulate your mind.
|
With film rights snapped up by an Oscar winning Hollywood production company, rights sold in a world record 43 territories, and rave blurbs from David Baldacci, Lee Child and A.
|
|
|
|
